ALKS vs GRMN · P/E 14, rev $1.56B vs P/E 28, rev $6.30B
Alkermes Plc (ALKS) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the ALKS and GRMN stock pages for the full models.
Not investment advice.